Show simple item record

dc.contributor.authorvon Bonsdorff, Mikaela
dc.contributor.authorvon Bonsdorff, Monika
dc.contributor.authorHaanpää, Maija
dc.contributor.authorSalonen, Minna
dc.contributor.authorMikkola, Tuija M.
dc.contributor.authorKautiainen, Hannu
dc.contributor.authorEriksson, Johan G.
dc.date.accessioned2018-04-10T09:39:40Z
dc.date.available2018-04-10T09:39:40Z
dc.date.issued2018
dc.identifier.citationvon Bonsdorff, M., von Bonsdorff, M., Haanpää, M., Salonen, M., Mikkola, T. M., Kautiainen, H., & Eriksson, J. G. (2018). Work-loss years among people diagnosed with diabetes : a reappraisal from a life course perspective. <i>Acta Diabetologica</i>, <i>55</i>(5), 485-491. <a href="https://doi.org/10.1007/s00592-018-1119-x" target="_blank">https://doi.org/10.1007/s00592-018-1119-x</a>
dc.identifier.otherCONVID_27913083
dc.identifier.otherTUTKAID_76871
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/57531
dc.description.abstractAims Early exit from the workforce has been proposed to be one of the unfavorable consequences of diabetes. We examined whether early exit from the workforce differed between persons who were and were not diagnosed with diabetes during their work career. Methods The cohort included 12,726 individuals of the Helsinki Birth Cohort Study, born between 1934 and 1944. Using data from nationwide registers, the cohort was followed up from early adulthood until they transitioned into retirement or died. Work-loss years were estimated using the restricted mean work years method. Results During a follow-up of 382,328 person-years for men and 349 894 for women, 36.8% transitioned into old age pension and 63.2% exited workforce early. Among men, 40.5% of those with and 32.8% of those without diabetes transitioned into old age pension (p=0.003). The corresponding numbers for women were 48.6% and 40.4% (p = 0.013), respectively. Mean age at exit from the workforce was 60.1 (95% confidence interval [CI], 59.6 to 60.7) years among men with diabetes and 57.6 (95% CI, 57.2 to 58.0) years among men without diabetes (p = 0.016). Among women, corresponding ages were 61.4 (95% CI, 60.8 to 61.9) years for those with diabetes and 59.5 (95% CI, 59.3 to 59.7) years for those without diabetes (p < 0.001). The difference in mean restricted work-loss years according to diabetes was 2.5 (95% CI 0.5 to 4.6) for men and 1.9 (95% CI 1.0 to 2.8) for women. Conclusion Among individuals followed up throughout their work career, those with a diabetes diagnosis exited the workforce approximately two years later compared to those without diabetes.en
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofseriesActa Diabetologica
dc.subject.otherdiabetes mellitus
dc.subject.otherdiabetes medication
dc.subject.otherearly exit from workforce
dc.subject.otherdisability pension
dc.subject.otherlife course
dc.subject.otheraging
dc.titleWork-loss years among people diagnosed with diabetes : a reappraisal from a life course perspective
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-201804051929
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.contributor.oppiaineGerontologia ja kansanterveysfi
dc.contributor.oppiaineGerontologian tutkimuskeskusfi
dc.contributor.oppiaineGerontology and Public Healthen
dc.contributor.oppiaineGerontology Research Centeren
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.date.updated2018-04-05T12:15:07Z
dc.description.reviewstatuspeerReviewed
dc.format.pagerange485-491
dc.relation.issn0940-5429
dc.relation.numberinseries5
dc.relation.volume55
dc.type.versionpublishedVersion
dc.rights.copyright© the Authors, 2018. This is an open access article distributed under the terms of the Creative Commons License.
dc.rights.accesslevelopenAccessfi
dc.relation.grantnumber294530
dc.relation.grantnumber307114
dc.subject.ysodiabetes
dc.subject.ysolääkehoito
dc.subject.ysoeläkkeelle siirtyminen
dc.subject.ysoepidemiologia
dc.subject.ysotyökyvyttömyys
dc.subject.ysotyökyvyttömyyseläkkeet
jyx.subject.urihttp://www.yso.fi/onto/yso/p8304
jyx.subject.urihttp://www.yso.fi/onto/yso/p10851
jyx.subject.urihttp://www.yso.fi/onto/yso/p4810
jyx.subject.urihttp://www.yso.fi/onto/yso/p11307
jyx.subject.urihttp://www.yso.fi/onto/yso/p10212
jyx.subject.urihttp://www.yso.fi/onto/yso/p3349
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.1007/s00592-018-1119-x
dc.relation.funderSuomen Akatemiafi
dc.relation.funderSuomen Akatemiafi
dc.relation.funderAcademy of Finlanden
dc.relation.funderAcademy of Finlanden
jyx.fundingprogramAkatemiatutkija, SAfi
jyx.fundingprogramAkatemiatutkijan tutkimuskulut, SAfi
jyx.fundingprogramAcademy Research Fellow, AoFen
jyx.fundingprogramResearch costs of Academy Research Fellow, AoFen
jyx.fundinginformationHBCS was supported by Finnish Foundation for Cardiovascular Research, Finnish Foundation for Diabetes Research, Juho Vainio Foundation, Novo Nordisk Foundation, Signe and Ane Gyllenberg Foundation, Samfundet Folkhälsan, Finska Läkaresällskapet, Liv och Hälsa, European Commission FP7 (DORIAN) Grant Agreement No. 278603 and EU H2020-PHC-2014-DynaHealth Grant No. 633595. The Academy of Finland supported MEvB (Grant Nos. 250681, 294530, 307114) and JGE (Grant Nos. 129369, 129907, 135072, 129255 and 126775).


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© the Authors, 2018. This is an open access article distributed under the terms of the Creative Commons License.
Except where otherwise noted, this item's license is described as © the Authors, 2018. This is an open access article distributed under the terms of the Creative Commons License.